Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000882095-25-000032
Filing Date
2025-08-07
Accepted
2025-08-07 17:14:25
Documents
87
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gild-20250630.htm   iXBRL 10-Q 2502433
2 2025 NON-EE DIRECTOR STOCK OPTION AGREEMENT gildq22025ex10202025non-ee.htm EX-10.20 85004
3 2025 NON-EE DIRECTOR RSU AGREEMENT gildq22025ex10332025non-ee.htm EX-10.33 81522
4 CEO CERTIFICATION gildq22025ex311ceocertific.htm EX-31.1 8066
5 CFO CERTIFICATION gildq22025ex312cfocertific.htm EX-31.2 7607
6 SECTION 906 CERTIFICATIONS gildq22025ex32section906ce.htm EX-32 5865
  Complete submission text file 0000882095-25-000032.txt   11877038

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gild-20250630.xsd EX-101.SCH 60565
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gild-20250630_cal.xml EX-101.CAL 110213
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gild-20250630_def.xml EX-101.DEF 295456
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gild-20250630_lab.xml EX-101.LAB 739561
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gild-20250630_pre.xml EX-101.PRE 523522
89 EXTRACTED XBRL INSTANCE DOCUMENT gild-20250630_htm.xml XML 2424447
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Filer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19731 | Film No.: 251195318
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)